Printer Friendly

The effect of the duration of In Vitro Maturation (IVM) on parthenogenetfic development of ovine oocytes.

Abstract

The aim of this study was to compare the effect of time of parthenogenetic activation (22 hr versus 27 hr after In Vitro Maturation-IVM) on in vitro development of ovine oocytes using either single (lonomycin 5 [micro]M for 5 min or Ethanol 7% for 7 min) or combined (ionomycin and ethanol with 6-DMAP 2 mM for 3 hr) activation treatments. The abattoir-derived in vitro matured activated oocytes were cultured in modified synthetic oviductal fluid and assessed for the cleavage, blastocyst, and hatching rates. The single-activated oocytes had a reduction in cleavage, blastocyst and hatching rates compared to the combined-activated oocytes (except for the cleavage at 27 hr). In single-treated groups the rates of cleavage and blastocyst were increased as the maturation time was extended from 22 hr to 27 hr. The numbers of total cells and Inner Cell Mass (ICM), though insignificant, were greater in combined-treated groups compared to the single treatment. The number of ICM in Eth+6-DMAP group activated at 27 hr was lower than 22 hr. Nonetheless, irrespective of the activation protocol, development to the blastocyst stage, the numbers of total cell, ICM, and cell allocation (ICM/total cells) were significantly lower in parthenogenetic than fertilized embryos. In conclusion, though the cleavage and blastocyst rates in single-treated groups were positively influenced by the extension of duration of IVM (27 hr), there was a trend of decreased numbers of total cells and ICM in slightly aged oocytes. Moreover, developmental potential of ovine parthenotes, especially in young oocytes, was improved by the addition of 6-DMAP to the activation regimen.

Avicenna / Med Biotech 2009; 1(3): 181--191

Keywords: Blastocyst, Ethanol, lonomycin, Parthenogenesis, Sheep

Introduction

Oocyte activation is one of the essential elements that determine the success of nuclear transfer and the subsequent development of cloned embryos. Failure to activate oocytes efficiently, in a simple manner constitutes one of the limiting steps for the success of cloning by nuclear transfer. Oocyte activation allows synchronization of cell cycle phase between the cytoplasm of the oocyte and the transferred nucleus, promoting nuclear reprogramming and maintenance of normal ploidy (1). The study of parthenogenetic activation also permits a greater understanding of the mechanisms of spontaneous activation, preventing it in in vitro fertilization systems, and allows investigating the comparative roles of paternal and maternal genomes in controlling early embryo development (2).

Artificial stimuli through elevating the cytoplasmic levels of calcium ions of oocytes aim to mimic the action of sperm cells during fertilization (3). Some artificial activation treatments promote an increase in intracellular free calcium concentrations by the release of calcium from cytoplasmic stores, such as Strontium (4) and lonomycin (5) while there are elements that promote influx of calcium from the extracellular medium, such as electrical stimulus. There are, however, elements that promote both effects, such as ethanol (5).

These treatments are commonly followed by the application of an inhibitor of protein phosphoiyiation (6-dimethylaminopurine; 6-DMAP) which prevents Maturation Promoting Factor (MPF) activation or an inhibitor of protein synthesis (cycloheximide, CHX) that prevents cyclin synthesis (6-9).

Among the deficiencies in the process of artificial activation, the age of oocyte (maturation time) could be an important contributing factor (6), (10). Activation is more easily achieved in aged oocytes due to the spontaneous reduction on MPF activity with aging of oocytes (11), (12) and changes in sensitivity of metaphase II (MII) oocytes to the internal calcium perturbation provoked by an artificial stimulus (13). However, it is known that such aging, apart from its negative cytoplasmic changes, causes alterations in components of the cytoskeleton of the oocyte (14-16), impairs enucleation through changes in the location and organization of the second meiotic spindle (17), (18), affects embryonic development after fusion (10-19) and increases the frequency of fragmentation and caspases activation, responsible for cell apoptosis (20). In this context, dependence on oocyte age for parthenogenetic activation can be minimized by promotion of multiple intracellular calcium pulses or combination of different artificial activation treatments (22), (23).

In some species the response of young oocytes to parthenogenetic activation is low (24), (25) and aged oocytes are often used as recipient oocytes for nuclear transfer of embryonic nuclei (18). The potential of aged mouse (26) and rabbit (16) NT oocytes receiving embryonic nuclei to develop into blastocyst is higher than that of young oocytes. In contrast, there are reports indicating the lower developmental potential of aged bovine (27) and mouse (28) oocytes after parthenogenetic activation compared to the young oocytes.

Although an age-dependent activation response has been described previously in several species, including the mouse (29), cow (24), (30), and pig (31), there are no relevant studies on the effect of oocyte age on parthenogenetic activation in sheep. In the current study, as a primary objective, the effect of maturation time (22 hr vs 27 hr) of ovine oocytes on efficiency of activation treatments, and as a secondary objective the comparison between the effect of single or combined activation treatments on ovine parthenogenesis were evaluated. In this evaluation, the cleavage and blastocyst rates, the capacity of the blastocyst to hatch from the zona pellucida, blastocyst cell numbers and the cell allocation were analyzed.

Materials and Methods

Except where otherwise indicated, all chemicals were obtained from the Sigma (St. Louis, MO USA).

Oocyte collection and in vitro maturation

Prepubertal and adult ovine ovaries were collected at a local slaughterhouse and transported to the laboratory within 2 to 3 hr in normal saline at temperature between 25 and 35[degrees]C. The ovaries were washed 3 times with prewarmed (37[degrees]C) fresh saline, and all visible follicles with a diameter of 2 to 6 mm were aspirated using gentle vacuum (30 mmHg) via a 20 gauge short beveled needle connected to a vacuum pump. The follicle content was released in preincubated hepcs-buffered TCM 199, supplemented with 50 IU/ml heparin.

The method for in vitro maturation and production of sheep embryo was the same as described by Thompson et at (32) with minor modification.

Briefly, the oocytes, with at least 3 layers of cumulus cells (COCs: Cumulus-Oocyte Complexes), with a uniform granulated cytoplasm and homogenous distribution of lipid droplets in the cytoplasm, were selected for the experiments. Before culturing, the oocytes were washed in Hepes-buffered TCM 199 (H-TCM199) supplemented with 5% FBS (Fetal bovine serum, Gibco 10270), and 2 mM glutamine. The Oocyte Culture Medium (0CM) consisted of bicarbonate-buffered TCM199 with 2 mM L-glutamine supplemented with 0.02 mg/ml cysteamine, 1 IU/ml hCG, 0.05% IU/ml FSH, 1 [micro]g/ml [E.sub.2], 100 IU/ml penicillin, 100 [micro]g/ml streptomycin, 10% FBS (Fetal bovine serum, Gibco 10270), and 0.2 mM Na-Pyruvate. The selected COCs were pooled and randomly distributed in maturation droplets (15 oocytes in 50 [micro]l) and covered by sterile paraffin oil in a 60 mm Petri dish (Falcon 3004; Becton & Dickinson, Franklin Lakes, NJ) and were then incubated for 22 and 27 hrs at 39 [degrees]C under an atmosphere of 5%[CO.sub.2] and 100% humidity.

Preparation of sperm and In Vitro Fertilization (IVF)

After IVM, the oocytes were washed four times in H-SOF (HEPES-synthetic oviductal fluid) and once in fertilization medium and were then transferred into the fertilization droplets. Fresh semen was collected from a Lori-Bakhtiari ram of proven fertility. For swim up, 80-100 [micro]l of semen was kept under 1 ml of BSA-HSOF in 15 ml conical tube at 39 [degrees]C for up to 45 min. After swim up, the 700-800 [micro]l: of medium was gently taken off the top of the suspension and were then added into 15 ml conical tube containing 3 ml of BSA-HSOF, centrifuged twice at 200xg for 3 min and the final pellet was resuspended with BSA-HSOF. The oocytes were inseminated with 1.0 x [10.sup.6] normal, motile spermatozoa/ml. The fertilization medium was SOF (as originally described by Tervit et al) (33) and enriched with 20% heat inactivated estrous sheep serum. A 5 pl aliquot of sperm suspension, (1.0 x [10.sup.6] sperm/ml), was added into the fertilization droplets (45 [micro]l) containing 10 oocytes. Fertilization was carried out by coincubation of sperm and oocytes for 22 hr at 39 [degrees]C in an atmosphere of 5% [CO.sub.2] in humidified air. After IVF, presumptive zygotes were denuded of surrounding cumulus cells by vortexing for 2 min in H-SOF containing 0.1% hyaluronidase and were then transferred to culture drops.

Activation of oocyte

Methods for activation of oocytes were modified from Susko-Parrish et al (34). After IVM (22 and 27 hrs), cumulus cells were removed by incubation in H-SOF containing 0.1% hyaluronidase at 39 [degrees]C for 2 min followed by vortexing for 3 Mill. Denuded oocytes were pooled and randomly allocated into single or combined treatment groups. In single treatment groups the oocytes were treated with either lonomycin (5 [micro]M for 5 min) or ethanol (7% for 7 min). After 5 min exposure to Ionomycin, the oocytes were then rinsed in H-SOF containing 30 mg/ml BSA to stop activation. All of the chemicals for oocyte activation were dissolved in H-SOF medium supplemented with 1 mg/ml Bovine Serum Albumin (BSA), except ethanol which was supplemented with 0.1 mg/ml PVP. In combined treatment, after oocyte activation with the same concentrations of Ionomycin or ethanol as in the single treatment, the oocytes were then incubated in 2.0 mM 6-DMAP for 3 hr. Following activation, the oocytes were washed twice in H-SOF medium and transferred to the culture medium.

A summary of the treatment groups is presented in the below. Each treatment consisted of at least 5 replicates:

Group IVF The in vitro matured oocytes for 22 and 27 hrs were fertilized with fresh semen (control)

Group Io: Denuded oocytes activated with 5 [micro]m Ionomycin for 5 min

Group Io+6-DMAP: Denuded oocytes activated with 5 [micro]m Ionomycin for 5 min+ 2 mM6-DMAP for 3 hr

Group Eth: Denuded oocytes activated with 7% ethanol for 7 min

Group Eth+6-DMAP: Denuded oocytes activated with 7% ethanol for 7 min+2 mM 6-DMAP for 3 hr

In vitro culture

Presumptive zygotes in IVF group and activated oocytes in parthenogenetic groups were allocated to 20 [micro]l culture drops (five to six embryos/drop) containing SOF supplemented with 2% (v/v) BME-essential amino acids, 1% (v/v) MEM-nonessential amino acids, 1 mM glutamine and 8 mg/ml fatty acid free BSA. Embryos were cultured for 8 days at 39 [degree]C under mineral oil in a humidified atmosphere of 5% [CO.sub.2], 7% [0.sub.2]. On the third and fifth days of culture (Day 0 defined as the day of fertilization), 10% charcoal stripped Fetal Bovine Serum (FBS) was added to the medium. The rates of cleaved embryos (day 3) and blastocysts (day 7) were expressed on the basis of the number of oocytes at the onset of culture. The percentage of hatched blastocysts on day 8 was expressed on the basis of the total number of blastocysts present on day seven.

Differential staining

Differential staining of Inner Cell Mass (ICM) and Trophectoderm (TE) compartments was carried out on day 7 blastocysts. Briefly, blastocysts were incubated in Triton X-100 prepared in the base medium (H-SOF containing 5 mg/ml BSA) for 20 sec. The blastocysts were then stained in the base medium containing 30 [micro]g/ml Propidium Iodide (PI) for 1 min. After two washes in the base medium, the blastocysts were transferred in ice-cold ethanol containing 10 [micro]g/ml Hoechst 33342 for 15 min. The blastocysts were directly mounted into the small droplet of glycerol on glass slide and examined under an epifluorescent microscope (IX71 Olympus, Tokyo, Japan). The ICM nuclei appeared blue, caused by DNA labeling with the membrane permeable Hoechst 33342, and trophoblastic cells appeared red due to staining of nuclear DNA with the membrane impermeable PI.

Statistical analysis

Data were collected over at least five replicates. All proportional data were subjected to an arc-sine transformation, and the transformed values were analyzed using one-way ANOVA. When the ANOVA revealed a significant effect, comparison of the means between the groups was performed using Tukey test. When normality test was failed the Kruskal-Wallis One Way Analysis of Variance on Ranks was applied. A p<0.05 level was considered significant (SPSS version 11.5). Data was expressed as mean[+ or -]SEM.

Results

Effect of oocyte age on development of parthenotes

As shown in Table 1, two maturation times were considered to compare the effect of four activation regimens on parthenogenesis of ovine oocytes matured in vitro. The cleavage rates of artificially activated oocytes after 22 hr of culture, in groups receiving either Io or Eth was lower than groups receiving Io+6-DMAP and Eth+6-DMAP (p<0,001). How ever, the difference between Eth and Eth+6-DMAPgroups was not significant (p>0.05). The cleavage rate in the combined treatment groups (Io+6-DMAP and Eth+6-DMAP) was comparable with the IVF group. There was not significant difference between the IVF and the artificially activated oocytes after 27 hr of culture in terms of cleavage rate (p>0.05). The cleavage rates were significantly increased in groups Io and Eth when the maturation time was extended from 22 to 27 hrs (p<0.05).
Table 1. Comparison of in vitro development of ovine oocytes
activated by lonomycin or Ethanol alone or in combination with
6-DMAPat 22 or 27 hr after in vitro maturation

              Oocyte          Cleavage              Biasitocyst

Experimental    No.            (mean [+ or             (mean [+ or
   Groups                      -] SEM)                 -] SEM)

                22 hr  27        22 hr       27hr        22 hr
                       hr

IVF(1)           156  167   82.2 [+ or  85.6 [+ or    41.0 [+ or
                            -] 3.2 (a)      -] 3.6    -] 3.2 (a)

Io(2)            147  149   46.6 [+ or  75.4 [+ or     3.8 [+ or
                           -] 6.9 (b),  -] 5.9 (B)   -] 2.1 (b),
                                   (A)                       (A)

Io+6-DMAP        149  151   80.8 [+ or  82.8 [+ or    26.0 [+ or
                            -] 5.4 (a)      -] 3.3    -] 2.9 (C)


Eth(3)           151  153   50.4 [+ or  73.5 [+ or     3.6 [+ or
                           -] 6.9 (b),  -] 3.3 (B)   -] 2.0 (b),
                              (c), (A)                       (A)

Eth+6-DMAP       139  159   70.7 [+ or  80.2 [+ or    18.8 [+ or
                            -] 3.8(c),      -] 4.5       -] 2(c)
                                   (a)

                         Hatchedblastocyst

Experimental             (mean [+ or -] SEM)
   Groups

                   27 hr              22 hr      27 hr


IVF(1)        42.6 [+ or           71.1 [+ or   77.0 [+ or
              -] 3.4 (a)           -] 1.7 (a)  -] 2.6 (a)

Io(2)         15,2 [+ or         o.o [+ or -]    5.0 [+ or
              -] 1,9(M),              o.o (b)   -] 5.0 (b)
                    (B)

Io+6-DMAP      29.6 [+ or          37.8 [+ or   59.2 [+ or
               -] 2.2 (C)     -] 4.6 (C), (A)  -] 2.9 (a),
                                                  (B)

Eth(3)        14.6 [+ or          8.3[+ or -]    4.0 [+ or
             -] 1.3 (b),              8.3 (b)   -] 4.0 (b)
                    (B)

Eth+6-DMAP    24.4 [+ or           41.7[+ or    54.7 [+ or
             -] 1.4 (d),           -]8.6 (C)   -] 12.1 (a)
                     (c)

(a.), (b.), (c.), (d.) Means[+ or -]SEM; different lowercase letters
indicate statistical differences into columns (p<0.001)

(A.), (B.) Means[+ or -]SEM; different uppercase letters indicate
statistical differences in the same embryonic development stage
(p<0.05)

(1.) In vitro fertilization; (2.) Ionomycin; (3.) Ethanol


The blastocyst rates of artificially activated oocytes after 22 hr of culture in groups receiving either Io or Eth was lower than groups receiving Io+6-DMAPand Eth+6-DMAP (p<0.001). The blastocyst rates in groups receiving Io+6-DMAP and Eth+6-DMAP after 27 hr of culture was higher (p<0.001) than groups receiving either Io or Eth (except for Eth+6-DMAP and Io). The corresponding value in IVF group, however, was significantly higher than parthenogenetically activated oocytes at both 22 and 27 hrs of culture (p<0.001). The blastocyst rates were significantly increased in groups Io and Eth when the maturation time was increased from 22 to 27 hrs (p<0.05).

The hatching rates in combined treatment groups after both 22 and 27 hrs of culture were significantly higher than single treatment groups (p<0.001). The corresponding rate, however, was significantly higher in IVF group compared to the artificially activated oocytes after 22 hr of culture (p<0.001). The hatching rate was significantly increased in group Io+6-DMAP as the maturation time was increased to 27 hr (p<0.05).

Effect of oocyte age on cell number of parthenogenetically produced blastocysts

The cell numbers in parthenogenetically developed blastocysts were lower than (p<0.001) in vitro produced embryos for 22 and 27 hrs of oocyte maturations (Table 2, Figure 1). A comparison between blastocyst cell numbers in embryos derived from the oocytes matured in vitro for 22 and 27 his did not show any significant difference among experimental groups (p>0.05). The number of inner cell mass and its proportion to the total cells were significantly higher in IVF derived blastocysts than parthenogenetically developed blastocysts for 22 and 27 hrs of oocyte maturation (p<0.00 ). In group Eth+6-DMAP, the mean number of ICM was significantly higher in oocytes activated after 22 hr of culture compared to 27 hr (p<0.05).

[FIGURE 1 OMITTED]
Table 2. Comparison of cell numbers in parthenogenetically
developed blastocyst derived from ovine oocytes activated at
22 or 27 hr after in vitro maturation

              Blastocyst         Cell no.              ICM no.
                                      per                  per
                               Blastocyst           Blastocyst

Experimental         No.         (mean [+             (mean [+
groups                              or -]                or -]
                                     SEM)                 SEM)

                   22 hr  27        22 hr   27 hr        22 hr   27hr
                          hr

IVF (1)               32  34  145.3 [+ or   160.4   30.0 [+ or   32.1
                                  -] 14.9   [+ or   -] 2.3 (a)     [+
                                      (a)      -]               or -]
                                             14.8                 2.4
                                              (a)                 (a)

Io (2)                 6  14   29.5 [+ or    28.4    3.0 [+ or    2.6
                               -] 6.0 (b)   [+ or   -] 0.5 (b)     [+
                                           -] 2.3               or -]
                                              (b)                 0.2
                                                                  (b)

Io+6-DMAP             21  26   63.1 [+ or    52.0    5.3 [+ or    4.3
                               -] 8.8 (b)   [+ or   -] 0.7 (b)     [+
                                           -] 7.5               or -]
                                              (b)                 0.6
                                                                  (b)

Eth (3)                5  14   29.0 [+ or    28.7    3.4 [+ or    2.7
                               -] 5.7 (b)   [+ or   -] 0.5 (b)     [+
                                           -] 2.4               or -]
                                              (b)                 0.3
                                                                  (b)

Eth+6-DMAP            18  21   50.8 [+ or    43.3    4.6 [+ or    3.1
                               -] 5.9 (b)   [+ or  -] 0.6 (b),     [+
                                           -] 4.1          (A)  or -]
                                              (b)                 0.3
                                                                 (b),
                                                                  (B)

               ICM/total
                    cell


Experimental    (mean [+
groups             or -]
                    SEM)

                   22 hr     27
                             hr

IVF (1)       0.23 [+ or   0.22
                  -] 0.0     [+
                     (a)  or -]
                            0.0
                            (a)

Io (2)         0.1 [+ or    0.1
                  -] 0.0     [+
                     (b)  or -]
                            0.0
                            (b)

Io+6-DMAP     0.09 [+ or   0.09
                  -] 0.0     [+
                     (b)  or -]
                            0.0
                            (b)

Eth (3)       0.12 [+ or   0.09
                  -] 0.0     [+
                     (b)  or -]
                            0.0
                            (b)

Eth+6-DMAP     0.1 [+ or   0.08
                  -] 0.0     [+
                     (b)  or -]
                            0.0
                            (b)

(a.), (b.) Means [+ or -] SEM; different lowercase letters indicate
statistical differences into columns (p<0.001)

(A), (B) Means [+ or -] SEM; different uppercase letters indicate
statistical differences into rows of each subject (p<0.05).

(1.) In vitro fertilization; (2.) Ionomycin; (3.) Ethanol


Discussion

The most prominent manifestations of oocyte aging include an increased susceptibility to activating stimuli (13), (24), most probably through a decrease in MPF activity (12), (35), (36), the onset of anaphase II (36), (37), and partial exocytosis of cortical granules (38). it is known, however, that fertilization or artificial activation of aged oocytes resulted in abnormal development (39), (40). In this study, we were interested in testing the effects of the maturation time (oocyte age) on efficiency of chemical activators for activating ovine oocytes matured in vitro. The synergistic effect of lonomycin and ethanol with 6-DMAP (combined treatments) was also investigated.

The current results indicated that in young oocytes (maturation time, 22 hr) the cleavage rate was higher in parthenogenetically activated oocytes treated with combined treatment compared with single treatment (lonomycin or ethanol alone). In slightly aged oocytes (maturation time; 27 hr) there was no such difference between activated oocytes treated by either single or combined treatments. On the other hand, the cleavage rate in the oocytes receiving single treatment (lonomycin or ethanol) was positively influenced, as the age of oocytes was increased. Similarly, the blastocyst formation and hatching rates were positively influenced by the synergism between lonomycin or ethanol with 6-DMAP at both 22 and 27 hrs.

In the single treated groups, the blastocyst formation rates were significantly higher in the oocytes parthenogentically activated after 27 hr of culture compared with 22 hr. The hatching rate was significantly increased in group lonomycin-1-6-DMAP in oocytes activated at 27 hr of culture compared to the 22 hr. These findings was in agreement with earlier studies demonstrating the low response of young oocytes to parthenogenetic activation (24), (25), (41) and those studies in which aged oocytes were often used as recipient oocytes for nuclear transfer(18), (42)

In this context, the potential of the aged mouse (26) and rabbit (16) NT oocytes receiving embryonic nuclei to develop into blastocyst was higher than that of young oocytes. In contrast, in some species following the combined treatment the activation rate and the proportion of parthenogenetically activated oocytes developed to blastocyst stage in young oocytes was higher than aged counterparts (18), (28). The aged oocytes, however, had higher activation rates but lower developmental potential than young oocytes (6). Similarly, a higher development has been reported in the reconstructed oocytes cloned with young recipient oocytes (18). In artificially activated bovine oocytes, no differences in the percentages of cleavage and blastocyst development were observed between the oocytes matured for 20 and 24 his (43).

One possible explanation for this discrepancy between the current result and other reports could be due to the narrow age gap (5 hr) between treatment groups (22 and 27 hrs). There are, probably, other contributing factors such as the pattern of oocyte maturation (in vivo or in vitro) and the presence or absence of cumulus cells (44) and interspecies. differences which could influence the responsiveness of oocytes to artificial activators. There is even report indicating that the effect of oocytes aging on activation rate is strain-dependent (45).

It is known that calcium ionophore (A23187) treatment can induce a single intracellular calcium rise in MII oocytes and its consequence is the activation of several calcium dependent proteolytic pathways, leading to the destruction of cyclin B, reduction of MPF activity, and resumption of meiosis (46). In young oocytes, A23187 treatment alone caused a slower decrease in H1 kinase activity and no evident of MAPK alteration (19). In contrast in aged oocytes, activities of both kinases decreased after A23187 treatment, similar to the response in the combined treatments (A23187+6-DMAP). This may explain the higher proportion of cleavage in slightly aged oocytes compared to the young oocytes in single treated groups.

In young, newly matured oocytes, because of the active synthesis of proteins including cyclin B, a recovery of MPF activity would occur after single calcium stimulation because of a quick renewal of cyclin B (13), (47). Alternatively, calcium stimulation followed by treatment with a protein kinase inhibitor such as 6-DMAP could block the activity of newly synthesized MPF and lead to full activation of the newly matured oocytes (23), (48).

The current results confirmed the above statement indicating the presence of synergistic effects between Ionomycin or ethanol with 6-DMAP on activation, cleavage and development rates in ovine oocytes (19), (23), (49). The fact that the calcium elevation, induced by Ionomycin, destroys cyclin B (and related proteins) and the protein kinase inhibitor (6-DMAP), prevents the renewal of those proteins, could explain the effectiveness of the combined treatment in the current study as supported by previous reports (6), (23), (48), (50).

As documented, for oocyte activation and normal female pronuclear development and subsequent cytokinetics of the oocyte, the presence of high MPF activity is necessary. Moreover, the high frequency of fragmentation in aged oocytes is attributable to their low MPF activity (51). However, another factor such as pre-MPF, might be involved in the aging phenomena (35). In the current study, it seems the narrow age gap (5 hr) between oocytes in the two age groups has not been big enough to decrease the MPF activity below a critical threshold needed for normal development. Instead the extended maturation time of oocytes (27 hr), has probably, resulted in better cytoplasmic maturation which in turn led to the higher cleavage and blastocyst rates in groups receiving either lonomycin or ethanol. The quality of parthenotes, the numbers of total cell and ICM, however, were not positively influenced in the slightly aged oocytes. There is also report suggesting the occurrence of negative cytoplasmic changes in slightly in vivo aged oocytes (16).

As shown the addition of 6-DMAP to activation protocol could increase the susceptibility of young oocytes to activation. In partially aged oocytes, however, inspite of probably improved cytoplasmic maturation, the addition of 6-DMAP had no extra beneficial effect on the developmental rate. In addition, the blastocyst cell numbers and the numbers of ICM in parthenotes were higher, though not significant, in the combined treated groups compared with single treated groups in both young and partially aged oocytes. Compared to the young oocytes, the number of ICM was significantly decreased only in ethanol+6-DMAP group in aged oocytes. There was, however, a trend of a decreased total cell numbers in combined treatment groups and a decrease in the number of ICM in all the treated groups of aged oocytes.

This might be due to a decreased quality of blastocysts derived from slightly aged oocytes. This finding was in accordance with the report indicating the lower total cell numbers in the parthenogenetic blastocysts developed from aged oocytes compared with young oocytes (28). It seemed, if the age gap between young and aged oocytes was quite enough, the difference in the quality of parthenogenetically produced blastocysts would become more prominent. However, as aforementioned in some groups of activated oocytes the cleavage, blastocyst and hatching rates were significantly higher in slightly aged oocytes and in other groups there was a positive trend towards the slightly aged oocytes.

Another reason for the lower cleavage, blastocyst, and hatched blastocyst rates in single treated groups may be due to the higher incidence of haploidy compared to the combined treated groups. In general, if activated oocytes are allowed to extrude a second polar body, an aneuploid, specifically haploid, parthenote is induced. On the other hand, in single treated groups especially in young oocytes (22 hr) the probability of extrusion of the second polar body was increased. Whereas, the polar body extrusion was inhibited in combined-treated oocytes. Indeed, the instant destruction of the spindle in 6-DMAP-treated oocytes could lead to the inhibition of polar body extrusion. Therefore, the oocytes would go directly into interphase and only one diploid pronucleus would be formed (19).

It is also known that the haploid parthenotes were developmentally compromised prior to blastocyst stages in contrast to diploid parthenotes (52-54). In slightly aged oocytes because of spontaneous reduction of MPF activity, the incidence of haploidy was low. The low rate of haploidy besides, probably, the proper cytoplasmic maturation due to extension of duration of IVM might be the reasons for the higher rates of cleavage and blastocyst in slightly aged oocytes compared to the young oocytes in the single treated groups.

Similarly, the lower total cell number in single treated group may be attributed to the higher incidence of haploid parthenotes in single treated groups compared with combined treated ones. As indicated, the total cell number in haploid parthenotes is significantly less than that in diploid parthenotes (54). Moreover, the incidence of apoptosis in the haploid parthenotes is significantly higher than that of diploid parthenotes which can explain the decreased total cell number in haploid parthenotes compared to the diploid parthenotes (54).

As expected, in IVF-derived embryos all parameters were obviously higher than corresponding parameters in parthenogenetically developed embryos (except for cleavage at 27 hr) indicating the lower potential of parthenogenetically activated oocytes compared with fertilized counterparts. As documented, parthenogenetic embryos exhibit delayed development and reduced total cell and ICM of blastocysts compared with fertilized embryos (55), (56). These developmental defects have been hypothesized to result from genomic imprinting, insufficient parthenogenetic activation, suboptimal in vitro culture conditions, or ploidy (54), (57).

Another reason for lower cleavage and developmental rate in parthenogenetic embryos might be associated with cell death by apoptosis (58). Meanwhile, the high levels of cytoplasmic fragmentation due to apoptosis are associated with reduced blastocyst formation and lower blastocyst cell numbers (59), (60).

In conclusion, the extension of duration of IVM (from 22 to 27 hrs) in ovine oocytes improves the developmental rate of parthenogenetically produced embryos, especially in those activated with either Ionomycin or ethanol. There is, however, a trend of a decreased quality in those embryos developed from slightly aged oocytes. Moreover, the addition of 6-DMAP to activation protocol, improves developmental potential of ovine parthenotes particularly in young oocytes from both quantitative (cleavage, blastocyst, and hatching rates) and qualitative (blastocyst cell number and number of ICM) viewpoints.

Acknowledgement

The authors would like to thank the Research Institute of Animal Embryo Technology for technical and financial supports, Shahrekord University, Dr. A. Kheiri for his kind assistance in statistical analysis, Shooli Research Center and Shahrekord's slaughterhouse staff for their cooperation.

References

(1.) Campbell KHS. Nuclear equivalence, nuclear transfer, and the cell cycle. Cloning 1999;1(1): 3-15.

(2.) Solter D. Differential imprinting and expression of maternal and paternal genomes. Annu Rev Genet 1988;22:127-146.

(3.) Nakada K, Mizuno J. Intracellular calcium responses in bovine oocytes induced by spermatozoa and by reagents. Theriogenology 1998,50(2):269-282.

(4.) Cuthbertson KSR, Whittingham DG, Cobbold PH. Free Ca2+ increases in exponential phases during mouse oocyte activation. Nature 1981;294:754-757.

(5.) Loi P, Ledda S, Fulka J, Jr, Cappai P, Moor RM. Development of parthenogenetic and cloned ovine embryos: effect of activation protocols. Biol Reprod 1998;58(5):1177-1187.

(6.) Presicce GA, Yang X. Nuclear dynamics of parthenogenesis of bovine oocytes matured in vitro for 20 and 40 hours and activated with combined ethanol and cycloheximide treatment. Mol Reprod Dev 1994;37(1):61-68.

(7.) Cibelli JB, Stice SL, Golueke PJ, Kane JJ, Jerry J, Blackwell C, et al. Cloned transgenic calves produced from nonquiescent fetal fibroblasts. Science 1998;280(5367):1256-1258.

(8.) Wells DN, Misica PM, Tervit HR. Production of cloned calves following nuclear transfer with cultured adult mural granulose cells. Biol Reprod 1999;60(4):996-1005.

(9.) De Sousa PA, Winger Q, Hill JR, Jones K, Watson AJ, Westhusin ME. Reprogramming of fibroblast nuclei into bovine oocytes. Cloning 1999;1(1): 63-69.

(10.) Bordignon V, Smith LC. Telophase enucleation: an improved method to prepare recipient cytoplasts for use in bovine nuclear transfer. Mol Reprod Dev 1998;49(1):29-36.

(11.) Kikuchi K, Izaike Y, Noguchi J, Furukawa T, Daen FP, Niato K, et al. Decrease of histone HI kinase activity in relation to parthenogenetic activation of pig follicular oocytes matured and aged in vitro. J Reprod Fertil 1995;105:325-330.

(12.) Wu B, Ignotz G, Currie WB, Yang X. Dynamics of maturation promoting factor and its constituent proteins during in vitro maturation of bovine oocytes. Biol Reprod 1997;56:253-259.

(13.) Kubiak JZ. Mouse oocytes gradually develop the capacity for activation during the metaphase II arrest. Dev Biol 1989;136(2):537-545.

(14.) Collas P, Robl JM. Factors affecting the efficiency of nuclear transplantation in the rabbit embryo. Biol Reprod 1990;43(5):877-884.

(15.) Kim NH, Moon SJ, Prather RS, Day BN. Cytoskeletal alteration in aged porcine oocytes and parthenogenesis. Mol Reprod Dev 1996;43(4): 513-518.

(16.) Adenot PG, Szollosi MS, Chesne P, Chastant S, Renard JP. In vivo aging of oocytes influences the behavior of nuclei transferred to enucleated rabbit oocytes. Mol Reprod Dev 1997;46(3):325-336.

(17.) Dominko T, Chan A, Simerly C, Luetjens CM, Hewitson L, Martinovich C, et al. Dynamic imaging of the metaphase II spindle and maternal chromosomes in bovine oocytes: implications for enucleation efficiency verification, avoidance of parthenogenesis, and successful embryogenesis. Biol Reprod 2000;62(1):150-154.

(18.) Takano H, Koyama K, Kozai C, Kato Y, Tsunoda Y. Effect of aging of recipient oocytes on the development of bovine nuclear transfer embryos in vitro. Theriogenology 1993;39(4);909-917.

(19.) Liu L, Ju J-C, Yang X. Differential inactivation of maturation-promoting factor and mitogen activated protein kinase following parthenogenetic activation of bovine oocytes. Biol Reprod 1998;59(3):537-545.

(20.) Gordo AC, Wu H, He CL, Fissore RA. Injection of sperm cytosolic factor into mouse metaphase II oocytes induces different developmental fates according to the frequency of [Ca.sup.2+] oscillations and oocyte age. Biol Reprod 2000;62(5):1370-1379.

(21.) Vitullo AD, Ozil JP. Repetitive calcium stimuli drive meiotic resumption and pronuclear development during mouse oocyte activation. Dev Biol 1992;151(1):128-136.

(22.) Yazawa S, Aoyagi Y, Konishi M, Takedomi T. Characterization and cytogenetic analysis of Japanese Black calves produced by nuclear transfer. Theriogenology 1997;48(4):641-650.

(23.) Liu L, Ju J-C Yang X. Parthenogenetic development and protein patterns of newly matured bovine oocytes after chemical activation. Mol Reprod Dev 1998;49(3):298-307.

(24.) Ware CB, Barnes FL, Maiki-Laurila M, First NL. Age dependence of bovine oocyte activation. Gamete Res 1989;22(3):265-275.

(25.) Tsunoda Y, Kato Y. Nuclear transplantation of embryonic stem cells in mice. J Reprod Fertil 1993;98:537-540.

(26.) Taniguchi T, Taniguchi R, Kanagawa H. Influence of oocyte aging on developmental ability of reconstituted embryos produced from oocyte cytoplast and single blastomeres of two-cell stage embryos. J Vet Med Sci 1996;58(7):635-640.

(27.) Takano H, Koyama K, Kozai C, Shimizu S, Kato Y, Tsunoda Y. Effects of cell cycle stage of donor nuclei on the development of bovine nuclear transferred embryos. J Reprod Dev 1996;42(1): 61-65.

(28.) Liu G, Kato Y, Tsunoda Y. Aging of recipient oocytes reduces the development of cloned embryos receiving cumulus cells. J Reprod Dev 2007; 53(4):785-790.

(29.) Collas P, Balise JJ, Hofmann GA, Robl JM. Electrical activation of mouse oocytes. Theriogenology 1989;32(5):835-844.

(30.) Lee SH, Ko TH, Monaghan P, Lonergan P, Gallagher M, Gorden I. Successful in vitro development of ethanol activated bovine oocytes to the blastocyst stage following in vitro maturation. J Reprod Fertil Abstr Ser 1992;9:56.

(31.) Prochazka R, Kanka J, Sutovsky P, Fulka J, Motlik J. Development of pronuclei in pig oocytes activated by a single electric pulse. J Reprod Fertil 1992;96:725-734.

(32.) Thompson JG, Gardner DK, Pugh PA, McMillan WH, Tervit HR. Lamb birth weight is affected by culture system utilized during in vitro pre elongation development of ovine embryos. Biol Reprod 1995;53(6):1385-1391.

(33.) Tervit HR, Whittingham DG, Rawson LE. Successful culture in vitro of sheep and cattle ova. J Reprod Fertil 197230:493-497.

(34.) Susko-Parrish JL, Leibfried-Rutledge ML, Northey DL, Schutzkus V, First NL. Inhibition of protein kinases after induced calcium transient causes transition of bovine oocytes to embryonic cycles without meiotic completion. Dev Biol 1994;166(2):729-739.

(35.) Kikuchi K, Naito K, Noguchi J, Shimada. A, Kaneko H, Yamashita M, et al. Maturation/Mphase promoting factor: a regulator of aging in porcine oocytes. Biol Reprod 2000;63(3):715-722.

(36.) Xu Z, Abbott A, Kopf GS, Schultz RM, Ducibella T. Spontaneous activation of ovulated mouse eggs: time-dependent effects on M-phase exit, cortical granule exocytosis, maternal messenger ribonucleic acid recruitment, and inositol 1,4,5 trisphosphate sensitivity. Biol Reprod 1997;57(4): 743-750.

(37.) Abbott AL, Xu Z, Kopf GS, Ducibella T, Schultz RM. In vitro culture retards spontaneous activation of cell cycle progression and cortical granule exocytosis that normally occur in in vivo unfertilized mouse eggs. Biol Reprod 1998;59(6): 1515-1521.

(38.) Ducibella T, Dubey A, Gross V, Emmi A, Penzias AS, Layman L, et al. A zona biochemical change and spontaneous cortical granule loss in eggs that fail to fertilize in in vitro fertilization. Fertil Steril 1995;64(6):1154-1161.

(39.) Juetten J, Bavister BD. Effects of egg aging on in vitro fertilization and first cleavage division in the hamster. Gamete Res 1983;8(3):219-230.

(40.) Gordo AC, Rodrigues P, Kurokawa M, Jellerette T, Exley GE, Warner C, et al. Intracellular calcium oscillations signal apoptosis rather than activation in in vitro aged mouse eggs. Blot Reprod 2002; 66(6):1828-1837.

(41.) Nagai T. Parthenogenetic activation of cattle follicular oocytes in vitro with ethanol. Gamete Res 1987;16(3 ):243-249.

(42.) Bondioli KR, Westhusin ME, Looney CR. Production of identical bovine offspring by nuclear transfer. Theriogenology 1990;33(1):165-174.

(43.) Shen PC, Lee SN, Liu BT, Chu FH, Wang CH, Wu JS, et al. The effect of activation treatments on the development of reconstructed bovine oocytes. Anim Reprod Sci 2008;106(1-2):1-12.

(44.) Miao YL, Liu XY, Qiao TW, Miao DQ, Luo MJ, Tan JH. Cumulus cells accelerate aging of mouse oocytes. Biol Reprod 2005;73(5):1025-1031.

(45.) Tsunoda Y, Sugie T. Activation of mouse eggs in vitro with ethanol treatment, and the effects of blastomere fusion and microinjection of cytoplasm from fertilized egg on the survival of parthenogenetic egg. Jpn J Fertil Steril 198732:105-113.

(46.) Vincent C, Cheek TR, Johnson MH. Cell cycle progression of parthenogenetically activated mouse oocytes to interphase is dependent on the level of internal calcium. J Cell Sci 1992;103(2): 389-396.

(47.) Winston NJ, McGuiness 0, Johnson MH, Maro B. The exit of mouse oocytes from meiotic M-phase requires intact spindle during intracellular calcium release. J Cell Sci 1995;108(1):143-151.

(48.) Soloy E, Kanka J, Viuff D, Smith SD, Callesen H Greve T. Time course of pronuclear deoxyribonucleic acid synthesis in parthenogenetically activated bovine oocytes. Biol Reprod 1997;57:27-35.

(49.) Tian XC, Lonergan P, Jeong BS, Evans AC, Yang X. Association of MPF, MAPK, and nuclear progression dynamics during activation of young and aged bovine oocytes. Mol Reprod Dev 2002; 62(1):132-138.

(50.) Wang ZG, Wang W, Yu SD, Xu ZR. Effects of different activation protocols on preimplantation development, apoptosis and ploidy of bovine parthenogenetic embryos Anim Reprod Sci 2008; 105(3-4):292-301

(51.) Shiina N, Moriguchi T, Ohta K, Gotoh Y, Nishida E. Regulation of a major microtubule-associated protein by MPF and MAP kinase, EMBO J 1992; 11(11):3977-3984.

(52.) Henery CC, Kaufman MH. Cleavage rate of haploid and diploid parthenogenetic mouse embryos during the preimplantation period. Mol Reprod Dev 1992;31(4):258-263.

(53.) Kim NH, Uhm SJ, Ju JY, Lee HT, Chuing KS. Blastocoele formation and cell allocation to the inner cell mass and trophectoderm in haploid and diploid pig parthenotes developing in vitro. Zygote 1997;5:365-370.

(54.) Liu L, Trimarchi JR, Keefe DL. Haploidy but not parthenogenetic activation leads to increased incidence of apoptosis in mouse embryos. Biol Reprod 2002;66(1):204-210.

(55.) O'Neill GT, Rolfe LR, Kaufman MH. Developmental potential and chromosome constitution of strontium-induced mouse parthenogenones. Mol Reprod Dev 1991;30(3):214-219.

(56.) Hardy K, Handyside AH. Metabolism and cell allocation during parthenogenetic preimplantation mouse development. Mol Reprod Dev 1996;43(3): 313-322.

(57.) Bhak JS, Lee SL, Ock SA., Kumar BM, Choe SY, Rho GJ. Developmental rate and ploidy of embryos produced by nuclear transfer with different activation treatments in cattle. Anim Reprod Sci 2006;92(1-2)37-49.

(58.) Hao Y, Lai L, Mao J, Im GS, Bonk A, Prather RS. Apoptosis in parthenogenetic preimplantation porcine embryos. Biol Reprod 2004;70(6):1644-1649.

(59.) Hao Y, Lai L, Mao J, Im GS, Bonk A, Prather RS. Apoptosis and in vitro development of preimplantation porcine embryos derived in vitro or by nuclear transfer. Biol Reprod 2003;69(2):501-507.

(60.) Jurisicova A, Varmuza S, Casper RF. Programmed cell death and human embryo fragmentation. Mol Hum Reprod 1996;2(2):93-98.

* Corresponding Author: Abolfazi Shirazi, D.V.M., Ph.D., Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran, P.O. Box: 19615-1177

Tel: +98 21 22432020

Fax: +98 21 22432021

E-mail: shicaziabbas@yahoo.com

a.shirazi@avicenna.ac.ir

Received: 22 Nov 2009

Accepted: 13 Dec 2009

Abolfazi Shirazi * (1), (2), Amin Bahiraee (1), Ebrahim Ahmadi (1), Hassan Nazari (1), Banafsheh Heidari (2), and Sara Borjian (1)

(1.) Research Institute of Animal Embryo Technology, Shahrekord University, Shahrekord, Iran

(2.) Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
COPYRIGHT 2009 Avicenna Research Institute
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Original Article
Author:Shirazi, Abolfazi; Bahiraee, Amin; Ahmadi, Ebrahim; Nazari, Hassan; Heidari, Banafsheh; Borjian, Sar
Publication:Avicenna Journal of Medical Biotechnology (AJMB)
Article Type:Report
Date:Oct 1, 2009
Words:6724
Previous Article:Effects of sperm chromatin integrity on fertilization rate and embryo quality following intracytoplasmic sperm injection.
Next Article:Lack of association between tumor necrosis factor-alpha -308 G/A polymorphism and risk of developing late-onset alzheimer's disease in an Iranian...
Topics:

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters